• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经元细胞周期再进入增强 APPNLF 敲入小鼠的神经病理学特征。

Neuronal Cell Cycle Re-Entry Enhances Neuropathological Features in AppNLF Knock-In Mice.

机构信息

Neuroscience Program, Central Michigan University, Mount Pleasant, MI, USA.

Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.

出版信息

J Alzheimers Dis. 2021;82(4):1683-1702. doi: 10.3233/JAD-210091.

DOI:10.3233/JAD-210091
PMID:34219712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8461670/
Abstract

BACKGROUND

Aberrant cell cycle re-entry is a well-documented process occurring early in Alzheimer's disease (AD). This is an early feature of the disease and may contribute to disease pathogenesis.

OBJECTIVE

To assess the effect of forced neuronal cell cycle re-entry in mice expressing humanized Aβ, we crossed our neuronal cell cycle re-entry mouse model with AppNLF knock-in (KI) mice.

METHODS

Our neuronal cell cycle re-entry (NCCR) mouse model is bitransgenic mice heterozygous for both Camk2a-tTA and TRE-SV40T. The NCCR mice were crossed with AppNLF KI mice to generate NCCR-AppNLF animals. Using this tet-off system, we triggered NCCR in our animals via neuronal expression of SV40T starting at 1 month of age. The animals were examined at the following time points: 9, 12, and 18 months of age. Various neuropathological features in our mice were evaluated by image analysis and stereology on brain sections stained using either immunofluorescence or immunohistochemistry.

RESULTS

We show that neuronal cell cycle re-entry in humanized Aβ plaque producing AppNLF KI mice results in the development of additional AD-related pathologies, namely, pathological tau, neuroinflammation, brain leukocyte infiltration, DNA damage response, and neurodegeneration.

CONCLUSION

Our findings show that neuronal cell cycle re-entry enhances AD-related neuropathological features in AppNLF mice and highlight our unique AD mouse model for studying the pathogenic role of aberrant cell cycle re-entry in AD.

摘要

背景

细胞周期异常重新进入是阿尔茨海默病(AD)早期有充分文献记录的过程。这是疾病的早期特征,可能导致疾病发病机制。

目的

评估在表达人源化 Aβ 的小鼠中强制神经元细胞周期重新进入的效果,我们将我们的神经元细胞周期重新进入(NCCR)小鼠模型与 AppNLF 敲入(KI)小鼠进行了杂交。

方法

我们的神经元细胞周期重新进入(NCCR)小鼠模型是 Camk2a-tTA 和 TRE-SV40T 双转基因杂合小鼠。NCCR 小鼠与 AppNLF KI 小鼠杂交,生成 NCCR-AppNLF 动物。使用这种 tet-off 系统,我们通过 SV40T 在神经元中的表达在 1 个月大时触发我们动物的 NCCR。在以下时间点检查动物:9、12 和 18 个月大。通过对使用免疫荧光或免疫组织化学染色的脑切片进行图像分析和立体学评估,评估我们小鼠中的各种神经病理学特征。

结果

我们表明,在产生人源化 Aβ 斑块的 AppNLF KI 小鼠中,神经元细胞周期重新进入导致 AD 相关病理学的进一步发展,即病理性 tau、神经炎症、脑白细胞浸润、DNA 损伤反应和神经退行性变。

结论

我们的发现表明,神经元细胞周期重新进入增强了 AppNLF 小鼠中与 AD 相关的神经病理学特征,并强调了我们用于研究异常细胞周期重新进入在 AD 中的致病作用的独特 AD 小鼠模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/f383757285be/jad-82-jad210091-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/eb6cf61c9613/jad-82-jad210091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/417ce832fec5/jad-82-jad210091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/6c0d694f8ba0/jad-82-jad210091-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/f9d079d9333b/jad-82-jad210091-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/cb59d3b59272/jad-82-jad210091-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/d3b4635c2c93/jad-82-jad210091-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/f383757285be/jad-82-jad210091-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/eb6cf61c9613/jad-82-jad210091-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/417ce832fec5/jad-82-jad210091-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/6c0d694f8ba0/jad-82-jad210091-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/f9d079d9333b/jad-82-jad210091-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/cb59d3b59272/jad-82-jad210091-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/d3b4635c2c93/jad-82-jad210091-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bede/8461670/f383757285be/jad-82-jad210091-g007.jpg

相似文献

1
Neuronal Cell Cycle Re-Entry Enhances Neuropathological Features in AppNLF Knock-In Mice.神经元细胞周期再进入增强 APPNLF 敲入小鼠的神经病理学特征。
J Alzheimers Dis. 2021;82(4):1683-1702. doi: 10.3233/JAD-210091.
2
Gliosis Precedes Amyloid-β Deposition and Pathological Tau Accumulation in the Neuronal Cell Cycle Re-Entry Mouse Model of Alzheimer's Disease.在阿尔茨海默病神经元细胞周期重新进入小鼠模型中,胶质增生先于淀粉样β沉积和病理性tau蛋白积累。
J Alzheimers Dis Rep. 2020 Jul 14;4(1):243-253. doi: 10.3233/ADR-200170.
3
Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.转基因小鼠中细胞周期蛋白的激活是对神经元丢失的反应,而非对β-淀粉样蛋白和tau病理变化的反应。
J Alzheimers Dis. 2009;16(3):541-9. doi: 10.3233/JAD-2009-0993.
4
A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.一种靶向 NLRP3 炎性小体的新型抑制剂可减少阿尔茨海默病转基因小鼠的神经病理学并改善认知功能。
J Alzheimers Dis. 2021;82(4):1769-1783. doi: 10.3233/JAD-210400.
5
Abeta oligomers induce neuronal cell cycle events in Alzheimer's disease.淀粉样β寡聚体在阿尔茨海默病中诱导神经元细胞周期事件。
J Neurosci. 2008 Oct 22;28(43):10786-93. doi: 10.1523/JNEUROSCI.2441-08.2008.
6
Cell cycle re-entry in Alzheimer's disease: a major neuropathological characteristic?阿尔茨海默病中的细胞周期重新进入:一个主要的神经病理学特征?
Curr Alzheimer Res. 2009 Jun;6(3):205-12. doi: 10.2174/156720509788486590.
7
Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer's disease patients.3xTg-AD小鼠模型和阿尔茨海默病患者中神经元细胞周期重新进入与tau病理的不同时间顺序。
J Alzheimers Dis. 2015;43(1):57-65. doi: 10.3233/JAD-141083.
8
Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology.阿尔茨海默病神经病理学转基因小鼠模型中的环氧化酶(COX)-2与细胞周期活性
Neurobiol Aging. 2002 May-Jun;23(3):327-34. doi: 10.1016/s0197-4580(01)00282-2.
9
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.细胞周期重新进入介导的神经退行性变及其在阿尔茨海默病发病机制中的治疗作用。
Neurochem Int. 2009 Feb;54(2):84-8. doi: 10.1016/j.neuint.2008.10.013. Epub 2008 Dec 9.
10
Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.淀粉样β斑块形成和反应性神经胶质增生是 APP 敲入阿尔茨海默病小鼠模型认知缺陷诱导所必需的。
BMC Neurosci. 2019 Mar 20;20(1):13. doi: 10.1186/s12868-019-0496-6.

引用本文的文献

1
A neurodegeneration checkpoint mediated by REST protects against the onset of Alzheimer's disease.REST 介导的神经退行性变检查点可预防阿尔茨海默病的发生。
Nat Commun. 2023 Nov 2;14(1):7030. doi: 10.1038/s41467-023-42704-6.
2
Melatonin as a Harmonizing Factor of Circadian Rhythms, Neuronal Cell Cycle and Neurogenesis: Additional Arguments for Its Therapeutic Use in Alzheimer's Disease.褪黑素作为昼夜节律、神经元细胞周期和神经发生的协调因子:其在阿尔茨海默病治疗中应用的更多论据。
Curr Neuropharmacol. 2023;21(5):1273-1298. doi: 10.2174/1570159X21666230314142505.
3
E2F4DN Transgenic Mice: A Tool for the Evaluation of E2F4 as a Therapeutic Target in Neuropathology and Brain Aging.

本文引用的文献

1
Gliosis Precedes Amyloid-β Deposition and Pathological Tau Accumulation in the Neuronal Cell Cycle Re-Entry Mouse Model of Alzheimer's Disease.在阿尔茨海默病神经元细胞周期重新进入小鼠模型中,胶质增生先于淀粉样β沉积和病理性tau蛋白积累。
J Alzheimers Dis Rep. 2020 Jul 14;4(1):243-253. doi: 10.3233/ADR-200170.
2
Core cell cycle machinery is crucially involved in both life and death of post-mitotic neurons.核心细胞周期机制对于有丝分裂后神经元的生与死都至关重要。
Cell Mol Life Sci. 2020 Nov;77(22):4553-4571. doi: 10.1007/s00018-020-03548-1. Epub 2020 May 31.
3
HDAC1 modulates OGG1-initiated oxidative DNA damage repair in the aging brain and Alzheimer's disease.
E2F4DN 转基因小鼠:评估 E2F4 作为神经病理学和脑老化治疗靶点的工具。
Int J Mol Sci. 2022 Oct 11;23(20):12093. doi: 10.3390/ijms232012093.
4
Model scenarios for cell cycle re-entry in Alzheimer's disease.阿尔茨海默病中细胞周期重新进入的模型情景。
iScience. 2022 Jun 7;25(7):104543. doi: 10.1016/j.isci.2022.104543. eCollection 2022 Jul 15.
5
Recent Advances in the Modeling of Alzheimer's Disease.阿尔茨海默病建模的最新进展
Front Neurosci. 2022 Mar 31;16:807473. doi: 10.3389/fnins.2022.807473. eCollection 2022.
6
Genotoxic Damage During Brain Development Presages Prototypical Neurodegenerative Disease.大脑发育过程中的基因毒性损伤预示着典型的神经退行性疾病。
Front Neurosci. 2021 Dec 2;15:752153. doi: 10.3389/fnins.2021.752153. eCollection 2021.
HDAC1 调节衰老大脑和阿尔茨海默病中 OGG1 起始的氧化 DNA 损伤修复。
Nat Commun. 2020 May 18;11(1):2484. doi: 10.1038/s41467-020-16361-y.
4
Disease-associated astrocytes in Alzheimer's disease and aging.阿尔茨海默病和衰老中与疾病相关的星形胶质细胞。
Nat Neurosci. 2020 Jun;23(6):701-706. doi: 10.1038/s41593-020-0624-8. Epub 2020 Apr 27.
5
NLRP3 inflammasome activation drives tau pathology.NLRP3 炎性小体激活驱动 tau 病理。
Nature. 2019 Nov;575(7784):669-673. doi: 10.1038/s41586-019-1769-z. Epub 2019 Nov 20.
6
Role of Microglial Cells in Alzheimer's Disease Tau Propagation.小胶质细胞在阿尔茨海默病tau蛋白传播中的作用
Front Aging Neurosci. 2019 Oct 4;11:271. doi: 10.3389/fnagi.2019.00271. eCollection 2019.
7
Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project.全基因组关联分析痴呆及其临床表型揭示了与阿尔茨海默病相关的新基因座和三个因果关系网络:GR@ACE 项目。
Alzheimers Dement. 2019 Oct;15(10):1333-1347. doi: 10.1016/j.jalz.2019.06.4950. Epub 2019 Aug 28.
8
p35 Hemizygous Deletion in 5xFAD Mice Increases Aβ Plaque Load in Males but Not in Females.5xFAD 小鼠中 p35 半合子缺失增加雄性而非雌性的 Aβ 斑块负荷。
Neuroscience. 2019 Oct 1;417:45-56. doi: 10.1016/j.neuroscience.2019.08.017. Epub 2019 Aug 14.
9
Progressive neuroanatomical changes caused by Grin1 loss-of-function mutation.Grin1 功能丧失突变导致的进行性神经解剖变化。
Neurobiol Dis. 2019 Dec;132:104527. doi: 10.1016/j.nbd.2019.104527. Epub 2019 Jul 9.
10
Epigenetic dysregulation of enhancers in neurons is associated with Alzheimer's disease pathology and cognitive symptoms.神经元中增强子的表观遗传失调与阿尔茨海默病病理和认知症状有关。
Nat Commun. 2019 May 21;10(1):2246. doi: 10.1038/s41467-019-10101-7.